A pharmaceutical composition containing a compound of Formula (I) for treating an opioid receptor-associated condition. Also disclosed is a method for treating an opioid receptor-associated condition using such a compound. Further disclosed are two sets of thiazolidinone compounds of formula (I): (i) compounds each having an enantiomeric excess greater than 90% and (ii) compounds each being substituted with deuterium.
-
Paragraph 1062-1063
(2017/09/21)
Preparation of 3-Azetidinols with Non-Bulky 1-Alkyl Substituents
Cyclization of either the tetrahydropyranyl or trimethylsilyl ether of 1-(alkylamino)-3-chloro-2-propanols 1 followed by cleavage of the azetidinyl ether provides a general method for the preparation of 1-alkyl-3-azetidinols.Unhindered amines provide a more facile preparation of derivatives of 1, or its ethers, than do hindered amines, while hindered derivatives of 1 undergo more facile ring closure.
Higgins, Robert H.,Eaton, Quentin L.,Worth, Leroy,Peterson, Myra V.
p. 255 - 259
(2007/10/02)
More Articles about upstream products of 111043-48-2